The Marcus Corporation Reports Fourth Quarter and Full Year Fiscal 2022 Results
The Marcus Corporation (NYSE: MCS) reported a record Adjusted EBITDA for fiscal year 2022, totaling $85.1 million, a 142.5% increase from fiscal 2021. Total revenues for FY 2022 reached $677.4 million, marking a 47.8% increase. The hotel division exceeded pre-pandemic revenue levels, contributing significantly to operating income of $8.3 million. However, Q4 revenues decreased by 3.6%, resulting in a net loss of $9.3 million. Despite these challenges, the company anticipates continued improvement in both hotel and theatre divisions for fiscal 2023 due to growing travel demand and an expected increase in film releases.
- Record Adjusted EBITDA of $85.1 million for fiscal year 2022, a 142.5% increase.
- Total revenues increased to $677.4 million for FY 2022, up 47.8% from FY 2021.
- Positive operating income of $8.3 million in FY 2022 compared to a loss of $41.5 million in FY 2021.
- Hotel division revenues exceeded pre-pandemic fiscal 2019 levels.
- Q4 2022 revenues decreased by 3.6% year-over-year.
- Operating loss of $2.7 million in Q4 2022, down from operating income of $14.0 million in Q4 2021.
- Net loss of $9.3 million for Q4 2022 compared to net earnings of $6.4 million in Q4 2021.
- Q4 adjusted EBITDA fell to $16.6 million from $29.3 million in Q4 2021.
Annual operating income turns positive
“Thanks to contributions from both
Fourth Quarter Fiscal 2022 Highlights
-
Total revenues for the fourth quarter of fiscal 2022 were
, a$162.9 million 3.6% decrease from total revenues of for the fourth quarter of fiscal 2021.$169.0 million
-
Operating loss was
for the fourth quarter of fiscal 2022, compared to operating income of$2.7 million for the prior year quarter.$14.0 million
-
Net loss attributable to
The Marcus Corporation was for the fourth quarter of fiscal 2022, compared to net earnings attributable to$9.3 million The Marcus Corporation of for the same period in fiscal 2021. Net loss attributable to$6.4 million the Marcus Corporation for the fourth quarter of fiscal 2022 was negatively impacted by , or$6.7 million per share, of income tax expense due to net increases in valuation allowances for deferred state income taxes.$0.21
-
Net loss per diluted common share attributable to
The Marcus Corporation was for the fourth quarter of fiscal 2022, compared to net earnings per diluted common share attributable to$0.30 The Marcus Corporation of for the fourth quarter of fiscal 2021.$0.18
-
Adjusted EBITDA was
for the fourth quarter of fiscal 2022, compared to Adjusted EBITDA of$16.6 million for the prior year quarter. The decrease in Adjusted EBITDA was due to both the decrease in revenue and the normalization of staffing levels compared to the prior year when labor availability was limited.$29.3 million
Full Year Fiscal 2022 Highlights
-
Total revenues for fiscal 2022 were
, a$677.4 million 47.8% increase from total revenues of for fiscal 2021.$458.2 million
-
Operating income was
for fiscal 2022, compared to operating loss of$8.3 million for fiscal 2021.$41.5 million
-
Net loss attributable to
The Marcus Corporation was for fiscal 2022, compared to net loss attributable to$12.0 million The Marcus Corporation of for fiscal 2021. Net loss attributable to$43.3 million the Marcus Corporation for fiscal 2022 was negatively impacted by , or$7.4 million per share, of income tax expense related to net increases in valuation reserves for state income taxes.$0.23
-
Net loss per diluted common share attributable to
The Marcus Corporation was for fiscal 2022, compared to net loss per diluted common share attributable to$0.39 The Marcus Corporation of for fiscal 2021.$1.42
-
Adjusted EBITDA was
for fiscal 2022, a$85.1 million 142.5% increase compared to Adjusted EBITDA of for fiscal 2021.$35.1 million
Adjusted EBITDA reflects adjustments made by the company to eliminate the impact of noncash impairment charges during fiscal 2022 and fiscal 2021 and the favorable impact of government grants and federal tax credits received during fiscal 2021 for COVID-19 relief.
Marcus®
RevPAR increased at all company-owned properties during the fourth quarter and full year fiscal 2022 compared to the fiscal 2021 periods. The division outperformed its competitive sets by approximately 2.2 percentage points during the fourth quarter and 4.3 percentage points during fiscal 2022 compared to the pre-pandemic fiscal 2019 periods.
“Revenues, operating income and Adjusted EBITDA increased significantly in fiscal year 2022 thanks to strong leisure travel and improving group demand,” said
Group pace improved significantly during fiscal 2022, with the pace for group room revenue for fiscal 2023 now in-line with the pace in pre-pandemic fiscal 2019. For fiscal 2024, the pace of group room revenue is running significantly ahead of comparable pace at this time last year.
On
While the first quarter of fiscal 2023 is off to a strong start and the macro environment for theatrical exhibition is improving,
For the full year fiscal 2022 compared to fiscal 2021, revenues grew
Comparing admission revenues to pre-pandemic 2019 results,
“During fiscal 2022 we took significant steps forward in our recovery as our customers steadily returned throughout the year for a movie watching experience only found in theatres,” said
Marcus Theatres’ top five highest-performing films in the fourth quarter of fiscal 2022 were Black Panther: Wakanda Forever, Avatar: The Way of Water, Black Adam, Smile and Ticket to Paradise. Each of these films debuted with an exclusive theatrical window, which is once again becoming the preferred distribution model for major film studios.
In contrast with the fourth quarter of fiscal 2022, the first quarter of fiscal 2023 is off to a strong start with the high performing Avatar: The Way of Water continuing its blockbuster run, and several other films performing well during the first two months of the year including Puss in Boots: The Last Wish, M3GAN, A Man Called Otto and Ant Man & the Wasp: Quantumania. A strong film slate for 2023 features an expected increase in the quantity of wide releases and includes Creed III,
Balance Sheet and Liquidity
The Marcus Corporation’s financial position remains strong with
Diluted weighted average shares outstanding and diluted net earnings per common share include the dilutive effect of conversion of the Company’s convertible notes to the extent conversion is dilutive in each period. During the fourth quarter of fiscal 2021, diluted weighted average shares outstanding included 9.1 million shares from the dilutive effect of the convertible notes, which were excluded from diluted weighted average shares outstanding in the other periods presented as the convertible notes were antidilutive. Diluted weighted average shares outstanding does not include the benefit from the capped call transactions the Company entered into in connection with the issuance of the convertible notes, which mitigate the dilutive effect of the convertible notes by approximately 3.4 million shares during the fourth quarter of fiscal 2021. Upon conversion, the convertible notes may be settled, at the Company’s election, in cash, shares of common stock or a combination thereof.
Conference Call and Webcast
A telephone replay of the conference call will be available through
Non-GAAP Financial Measure
Adjusted EBITDA has been presented in this press release as a supplemental measure of financial performance that is not required by, or presented in accordance with, GAAP. The company defines Adjusted EBITDA as net earnings (loss) attributable to
Adjusted EBITDA is a key measure used by management and the company’s board of directors to assess the company’s financial performance and enterprise value. The company believes that Adjusted EBITDA is a useful measure, as it eliminates certain expenses and gains that are not indicative of the company’s core operating performance and facilitates a comparison of the company’s core operating performance on a consistent basis from period to period. The company also uses Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of its business strategies, to make budgeting decisions, and to compare its performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.
Adjusted EBITDA is a non-GAAP measure of the company’s financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP and it should not be construed as an inference that the company’s future results will be unaffected by unusual or non-recurring items. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. In addition, this non-GAAP measure excludes certain non-recurring and other charges and has its limitations as an analytical tool. You should not consider Adjusted EBITDA in isolation or as a substitute for analysis of the company’s results as reported under GAAP. In evaluating Adjusted EBITDA, you should be aware that in the future the company will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. The company’s presentation of Adjusted EBITDA should not be construed to imply that the company’s future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by the company may not be comparable to the measures disclosed by other companies.
About
Headquartered in
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects the COVID-19 pandemic, or future pandemics, may have on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (particularly following the COVID-19 pandemic, during which the release dates for certain motion pictures have been postponed); (3) the effects of theatre industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets; (5) the effects of adverse economic conditions on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in
Consolidated Statements of Earnings (Loss) (Unaudited) (in thousands, except per share data) |
|||||||||||||||
|
13 Weeks Ended |
|
52 Weeks Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
Revenues: |
|
|
|
|
|
|
|
||||||||
Theatre admissions |
$ |
47,557 |
|
|
$ |
56,890 |
|
|
$ |
198,485 |
|
|
$ |
130,740 |
|
Rooms |
|
24,480 |
|
|
|
20,357 |
|
|
|
107,699 |
|
|
|
77,650 |
|
Theatre concessions |
|
41,854 |
|
|
|
49,734 |
|
|
|
180,180 |
|
|
|
118,666 |
|
Food and beverage |
|
19,867 |
|
|
|
14,852 |
|
|
|
74,836 |
|
|
|
47,086 |
|
Other revenues |
|
20,387 |
|
|
|
20,078 |
|
|
|
82,560 |
|
|
|
65,331 |
|
|
|
154,145 |
|
|
|
161,911 |
|
|
|
643,760 |
|
|
|
439,473 |
|
Cost reimbursements |
|
8,802 |
|
|
|
7,137 |
|
|
|
33,634 |
|
|
|
18,771 |
|
Total revenues |
|
162,947 |
|
|
|
169,048 |
|
|
|
677,394 |
|
|
|
458,244 |
|
|
|
|
|
|
|
|
|
||||||||
Costs and expenses: |
|
|
|
|
|
|
|
||||||||
Theatre operations |
|
51,489 |
|
|
|
53,161 |
|
|
|
212,410 |
|
|
|
140,821 |
|
Rooms |
|
11,031 |
|
|
|
8,375 |
|
|
|
41,561 |
|
|
|
30,394 |
|
Theatre concessions |
|
17,070 |
|
|
|
18,054 |
|
|
|
73,124 |
|
|
|
47,681 |
|
Food and beverage |
|
15,947 |
|
|
|
11,313 |
|
|
|
59,272 |
|
|
|
36,833 |
|
Advertising and marketing |
|
6,874 |
|
|
|
4,874 |
|
|
|
23,877 |
|
|
|
16,069 |
|
Administrative |
|
18,052 |
|
|
|
17,535 |
|
|
|
74,755 |
|
|
|
63,350 |
|
Depreciation and amortization |
|
16,638 |
|
|
|
17,924 |
|
|
|
67,073 |
|
|
|
72,127 |
|
Rent |
|
6,537 |
|
|
|
6,365 |
|
|
|
26,037 |
|
|
|
25,594 |
|
Property taxes |
|
3,319 |
|
|
|
4,331 |
|
|
|
17,955 |
|
|
|
18,473 |
|
Other operating expenses |
|
8,402 |
|
|
|
3,899 |
|
|
|
37,865 |
|
|
|
23,817 |
|
Impairment charges |
|
1,525 |
|
|
|
2,034 |
|
|
|
1,525 |
|
|
|
5,766 |
|
Reimbursed costs |
|
8,802 |
|
|
|
7,137 |
|
|
|
33,634 |
|
|
|
18,771 |
|
Total costs and expenses |
|
165,686 |
|
|
|
155,002 |
|
|
|
669,088 |
|
|
|
499,696 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
(2,739 |
) |
|
|
14,046 |
|
|
|
8,306 |
|
|
|
(41,452 |
) |
|
|
|
|
|
|
|
|
||||||||
Other income (expense): |
|
|
|
|
|
|
|
||||||||
Investment income (loss) |
|
717 |
|
|
|
446 |
|
|
|
(45 |
) |
|
|
599 |
|
Interest expense |
|
(3,456 |
) |
|
|
(4,352 |
) |
|
|
(15,299 |
) |
|
|
(18,702 |
) |
Other income (expense) |
|
(586 |
) |
|
|
(629 |
) |
|
|
(2,131 |
) |
|
|
(2,510 |
) |
Gain on disposition of property, equipment and other assets |
|
804 |
|
|
|
255 |
|
|
|
1,071 |
|
|
|
3,163 |
|
Gain on sale of hotel |
|
6,274 |
|
|
|
— |
|
|
|
6,274 |
|
|
|
— |
|
Equity losses from unconsolidated joint ventures |
|
(39 |
) |
|
|
(92 |
) |
|
|
(143 |
) |
|
|
(92 |
) |
|
|
3,714 |
|
|
|
(4,372 |
) |
|
|
(10,273 |
) |
|
|
(17,542 |
) |
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) before income taxes |
|
975 |
|
|
|
9,674 |
|
|
|
(1,967 |
) |
|
|
(58,994 |
) |
Income tax expense (benefit) |
|
7,426 |
|
|
|
3,230 |
|
|
|
7,137 |
|
|
|
(15,701 |
) |
Net earnings (loss) |
|
(6,451 |
) |
|
|
6,444 |
|
|
|
(9,104 |
) |
|
|
(43,293 |
) |
Net earnings attributable to noncontrolling interests |
|
2,868 |
|
|
|
— |
|
|
|
2,868 |
|
|
|
— |
|
Net earnings (loss) attributable to |
$ |
(9,319 |
) |
|
$ |
6,444 |
|
|
$ |
(11,972 |
) |
|
$ |
(43,293 |
) |
|
|
|
|
|
|
|
|
||||||||
Net earnings (loss) per common share attributable to |
|
|
|
|
|
|
|
||||||||
|
$ |
(0.30 |
) |
|
$ |
0.18 |
|
|
$ |
(0.39 |
) |
|
$ |
(1.42 |
) |
|
|
|
|
|
|
|
|
||||||||
Weighted average shares outstanding - diluted |
|
31,509 |
|
|
|
40,607 |
|
|
|
31,488 |
|
|
|
31,360 |
|
Condensed Consolidated Balance Sheets (In thousands) |
|||||
|
(Unaudited) |
|
(Audited) |
||
|
|
|
|
||
|
|
|
|
||
Assets: |
|
|
|
||
|
|
|
|
||
Cash and cash equivalents |
$ |
21,704 |
|
$ |
17,658 |
Restricted cash |
|
2,802 |
|
|
6,396 |
Accounts receivable |
|
21,455 |
|
|
28,902 |
Government grants receivable |
|
— |
|
|
4,335 |
Refundable income taxes |
|
— |
|
|
22,435 |
Assets held for sale |
|
460 |
|
|
4,856 |
Other current assets |
|
17,474 |
|
|
15,364 |
Property and equipment, net |
|
715,765 |
|
|
771,192 |
Operating lease right-of-use assets |
|
194,965 |
|
|
217,072 |
Other assets |
|
89,973 |
|
|
100,151 |
|
|
|
|
||
Total Assets |
$ |
1,064,598 |
|
$ |
1,188,361 |
|
|
|
|
||
Liabilities and Shareholders' Equity: |
|
|
|
||
|
|
|
|
||
Accounts payable |
$ |
32,187 |
|
$ |
35,781 |
Taxes other than income taxes |
|
17,948 |
|
|
19,566 |
Other current liabilities |
|
78,787 |
|
|
80,152 |
Short-term borrowings |
|
— |
|
|
47,346 |
Current portion of finance lease obligations |
|
2,488 |
|
|
2,561 |
Current portion of operating lease obligations |
|
14,553 |
|
|
16,795 |
Current maturities of long-term debt |
|
10,432 |
|
|
10,967 |
Finance lease obligations |
|
15,014 |
|
|
17,192 |
Operating lease obligations |
|
195,281 |
|
|
216,064 |
Long-term debt |
|
170,005 |
|
|
204,177 |
Deferred income taxes |
|
26,567 |
|
|
26,183 |
Other long-term obligations |
|
44,415 |
|
|
57,963 |
Equity |
|
456,921 |
|
|
453,614 |
|
|
|
|
||
Total Liabilities and Shareholders' Equity |
$ |
1,064,598 |
|
$ |
1,188,361 |
Business Segment Information (Unaudited) (In thousands) |
||||||||||||||
|
Theatres |
|
Hotels/ Resorts |
|
Corporate Items |
|
Total |
|||||||
13 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
97,555 |
|
|
$ |
65,328 |
|
$ |
64 |
|
|
$ |
162,947 |
|
Operating income (loss) |
|
421 |
|
|
|
736 |
|
|
(3,896 |
) |
|
|
(2,739 |
) |
Depreciation and amortization |
|
11,874 |
|
|
|
4,676 |
|
|
88 |
|
|
|
16,638 |
|
Adjusted EBITDA |
|
13,964 |
|
|
|
5,622 |
|
|
(3,028 |
) |
|
|
16,558 |
|
|
|
|
|
|
|
|
|
|||||||
13 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
116,389 |
|
|
$ |
52,559 |
|
$ |
100 |
|
|
$ |
169,048 |
|
Operating income (loss) |
|
18,899 |
|
|
|
354 |
|
|
(5,207 |
) |
|
|
14,046 |
|
Depreciation and amortization |
|
12,847 |
|
|
|
5,000 |
|
|
77 |
|
|
|
17,924 |
|
Adjusted EBITDA |
|
28,484 |
|
|
|
4,387 |
|
|
(3,621 |
) |
|
|
29,250 |
|
|
|
|
|
|
|
|
|
|||||||
52 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
407,741 |
|
|
$ |
269,286 |
|
$ |
367 |
|
|
$ |
677,394 |
|
Operating income (loss) |
|
8,108 |
|
|
|
18,699 |
|
|
(18,501 |
) |
|
|
8,306 |
|
Depreciation and amortization |
|
47,560 |
|
|
|
19,160 |
|
|
353 |
|
|
|
67,073 |
|
Adjusted EBITDA |
|
59,950 |
|
|
|
38,904 |
|
|
(13,780 |
) |
|
|
85,074 |
|
|
|
|
|
|
|
|
|
|||||||
52 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
271,248 |
|
|
$ |
186,638 |
|
$ |
358 |
|
|
$ |
458,244 |
|
Operating income (loss) |
|
(27,559 |
) |
|
|
5,865 |
|
|
(19,758 |
) |
|
|
(41,452 |
) |
Depreciation and amortization |
|
51,654 |
|
|
|
20,192 |
|
|
281 |
|
|
|
72,127 |
|
Adjusted EBITDA |
|
24,918 |
|
|
|
24,413 |
|
|
(14,251 |
) |
|
|
35,080 |
|
Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues. |
Supplemental Data (Unaudited) (In thousands) |
||||||||||||||||
|
|
13 Weeks Ended |
|
52 Weeks Ended |
||||||||||||
Consolidated |
|
|
|
|
|
|
|
|
||||||||
Net cash flow provided by (used in) operating activities |
|
$ |
32,847 |
|
|
$ |
44,194 |
|
|
$ |
93,209 |
|
|
$ |
46,251 |
|
Net cash flow provided by (used in) investing activities |
|
|
22,517 |
|
|
|
1,635 |
|
|
|
(346 |
) |
|
|
10,883 |
|
Net cash flow provided by (used in) financing activities |
|
|
(47,653 |
) |
|
|
(36,750 |
) |
|
|
(92,411 |
) |
|
|
(47,168 |
) |
Capital expenditures |
|
|
(9,360 |
) |
|
|
(7,961 |
) |
|
|
(36,843 |
) |
|
|
(17,082 |
) |
Reconciliation of Net earnings (loss) to Adjusted EBITDA (Unaudited) (In thousands) |
|||||||||||||||
|
13 Weeks Ended |
|
52 Weeks Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
Net earnings (loss) attributable to |
$ |
(9,319 |
) |
|
$ |
6,444 |
|
|
$ |
(11,972 |
) |
|
$ |
(43,293 |
) |
Add (deduct): |
|
|
|
|
|
|
|
||||||||
Investment (income) loss |
|
(717 |
) |
|
|
(446 |
) |
|
|
45 |
|
|
|
(599 |
) |
Interest expense |
|
3,456 |
|
|
|
4,352 |
|
|
|
15,299 |
|
|
|
18,702 |
|
Other expense (income) |
|
586 |
|
|
|
629 |
|
|
|
2,131 |
|
|
|
2,510 |
|
Gain on disposition of property, equipment and other assets |
|
(804 |
) |
|
|
(255 |
) |
|
|
(1,071 |
) |
|
|
(3,163 |
) |
Gain on sale of hotel |
|
(6,274 |
) |
|
|
— |
|
|
|
(6,274 |
) |
|
|
— |
|
Equity losses from unconsolidated joint ventures |
|
39 |
|
|
|
92 |
|
|
|
143 |
|
|
|
92 |
|
Net earnings attributable to noncontrolling interests |
|
2,868 |
|
|
|
— |
|
|
|
2,868 |
|
|
|
— |
|
Income tax expense (benefit) |
|
7,426 |
|
|
|
3,230 |
|
|
|
7,137 |
|
|
|
(15,701 |
) |
Depreciation and amortization |
|
16,638 |
|
|
|
17,924 |
|
|
|
67,073 |
|
|
|
72,127 |
|
Share-based compensation expenses (a) |
|
1,134 |
|
|
|
2,643 |
|
|
|
8,170 |
|
|
|
9,316 |
|
Impairment charges (b) |
|
1,525 |
|
|
|
2,034 |
|
|
|
1,525 |
|
|
|
5,766 |
|
Government grants (c) |
|
— |
|
|
|
(7,397 |
) |
|
|
— |
|
|
|
(10,677 |
) |
Adjusted EBITDA |
$ |
16,558 |
|
|
$ |
29,250 |
|
|
$ |
85,074 |
|
|
$ |
35,080 |
|
(a) |
Non-cash charges related to share-based compensation programs. |
(b) |
Non-cash impairment charges related to two operating theatres in fiscal 2022 and two operating theatres, three permanently closed theatres and surplus theatre real estate for the fiscal 2021 periods. |
(c) |
Reflects nonrecurring state government grants and federal tax credits awarded to our theatres and hotels for COVID-19 relief. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301006220/en/
(414) 905-1036
investors@marcuscorp.com
Source:
FAQ
What were the total revenues for The Marcus Corporation in fiscal 2022?
What was the Adjusted EBITDA for The Marcus Corporation in fiscal 2022?
Did The Marcus Corporation report a profit or loss in Q4 2022?